Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study

Primary sclerosing cholangitis (PSC) is frequently associated with pruritus, which significantly impairs quality of life. Maralixibat is a selective ileal bile acid transporter (IBAT) inhibitor that lowers circulating bile acid (BA) levels and reduces pruritus in cholestatic liver diseases. This is...

Descripción completa

Detalles Bibliográficos
Autores principales: Bowlus, Christopher L., Eksteen, Bertus, Cheung, Angela C., Thorburn, Douglas, Moylan, Cynthia A., Pockros, Paul J., Forman, Lisa M., Dorenbaum, Alejandro, Hirschfield, Gideon M., Kennedy, Ciara, Jaecklin, Thomas, McKibben, Andrew, Chien, Elaine, Baek, Marshall, Vig, Pamela, Levy, Cynthia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187837/
https://www.ncbi.nlm.nih.gov/pubmed/37184523
http://dx.doi.org/10.1097/HC9.0000000000000153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187837/
https://www.ncbi.nlm.nih.gov/pubmed/37184523
http://dx.doi.org/10.1097/HC9.0000000000000153

Ejemplares similares